Clinical Trial Update: Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on long-term safety and tolerability of cariprazine for Bipolar I Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-06-13